Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Account Payables (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Change in Account Payables for 16 consecutive years, with -$399000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Account Payables fell 130.57% to -$399000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.5 million, a 151.68% decrease, with the full-year FY2024 number at $1.0 million, down 65.34% from a year prior.
  • Change in Account Payables was -$399000.0 for Q3 2025 at Xtant Medical Holdings, down from $10000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.7 million in Q4 2023 to a low of -$890000.0 in Q1 2025.
  • A 5-year average of $172473.7 and a median of $151000.0 in 2021 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: skyrocketed 813.04% in 2024, then tumbled 280.89% in 2025.
  • Xtant Medical Holdings' Change in Account Payables stood at $260000.0 in 2021, then tumbled by 211.15% to -$289000.0 in 2022, then skyrocketed by 682.01% to $1.7 million in 2023, then plummeted by 115.28% to -$257000.0 in 2024, then plummeted by 55.25% to -$399000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Change in Account Payables are -$399000.0 (Q3 2025), $10000.0 (Q2 2025), and -$890000.0 (Q1 2025).